The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorder-Reference-Cited by-同舟云学术

The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorder

Published:2019-03 Issue: Volume:246 Page:217-223
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

McIntyre Roger S.,Calabrese Joseph R.,Nierenberg Andrew A.,Farahmand Khodayar,Yonan Chuck,Siegert Scott,Burke Joshua

Funder

National Natural Science Foundation of China

Canadian Institutes of Health Research

Stanley Medical Research Institute

Brain and Behavior Research Foundation

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference29 articles.

1. Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial;Anderson;Lancet Psychiatry,2017

2. A rating scale for drug-induced akathisia;Barnes;Br. J. Psychiatry,1989

3. Evidence-based guideline: treatment of tardive syndromes: report of the Guideline Development Subcommittee of the American Academy of Neurology;Bhidayasiri;Neurology,2013

4. Tardive dyskinesia prevalence in the period of second-generation antipsychotic use: a meta-analysis;Carbon;J. Clin. Psychiatry,2017

5. RE-KINECT: A prospective real-world dyskinesia screening study and registry in patients with mood/anxiety disorders prescribede antipsychotic agents;Caroff,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of VMAT2 inhibitors on suicidality and parkinsonism: report utilizing the United States Food and Drug Administration adverse event reporting system;International Clinical Psychopharmacology;2024-05-11

2. Efficacy and Safety of Valbenazine in Japanese Patients With Tardive Dyskinesia and Schizophrenia/Schizoaffective Disorder or Bipolar Disorder/Depressive Disorder;Journal of Clinical Psychopharmacology;2024-03

3. Efficacy and safety of valbenazine in Japanese patients with tardive dyskinesia: A multicenter, randomized, double‐blind, placebo‐controlled study ( J‐KINECT );Psychiatry and Clinical Neurosciences;2022-09-17

4. Pathophysiology, prognosis and treatment of tardive dyskinesia;Therapeutic Advances in Psychopharmacology;2022-01

5. Advances in the psychopharmacotherapy of bipolar disorder type I;Expert Opinion on Pharmacotherapy;2021-03-26